# National Therapy Products Inc. - Inspection Records

Source: https://www.keypedia.com/companies/national-therapy-products-inc/2de1222b-aa0d-4437-9626-62168de0b330

> Inspection records and compliance data for National Therapy Products Inc. in Brampton, None. Access full analysis and detailed observations.

---

## Details

- Name: National Therapy Products Inc.
- FEI Number: 3003445500
- City: Brampton
- State: None
- Country Name: Canada
- Address Line 1: 420 Deerhurst Dr Unit 3
- Zip Code: None

## Related Documents

- [483 - National Therapy Products Inc. - 2023-04-20](https://www.keypedia.com/records/483/national-therapy-products-inc/ecc1d273-663e-40c6-b56f-d325b4b3361b) — source: FDA, date: April 20, 2023
- [FDA Inspection 1205602 - National Therapy Products Inc. - 2023-04-20](https://www.keypedia.com/records/fda_inspections/national-therapy-products-inc/61b000bb-ec68-47ff-be70-ecb039fc87f5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 20, 2023
- [FDA Inspection 1205602 - National Therapy Products Inc. - 2023-04-20](https://www.keypedia.com/records/fda_inspections/national-therapy-products-inc/126185c0-830e-4b38-9c09-39589c9d673c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 20, 2023
- [FDA Inspection 1115686 - National Therapy Products Inc. - 2020-01-21](https://www.keypedia.com/records/fda_inspections/national-therapy-products-inc/2e39e457-aac9-4b76-99c5-39d03e5489ea) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 21, 2020
- [FDA Inspection 1115686 - National Therapy Products Inc. - 2020-01-21](https://www.keypedia.com/records/fda_inspections/national-therapy-products-inc/881ed628-c873-4efa-9ea0-a3c3a11ef653) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 21, 2020
- [FDA Inspection 732179 - National Therapy Products Inc. - 2011-06-21](https://www.keypedia.com/records/fda_inspections/national-therapy-products-inc/252d0169-b4af-4137-80c4-019ac096d481) — classification: Official Action Indicated (OAI), source: FDA, date: June 21, 2011
- [FDA Inspection 732179 - National Therapy Products Inc. - 2011-06-21](https://www.keypedia.com/records/fda_inspections/national-therapy-products-inc/fdc45c1c-31e8-4ba5-b5df-9f87a2a8b6db) — classification: Official Action Indicated (OAI), source: FDA, date: June 21, 2011

## Related Companies

- [Philips Respironics, Inc.](https://www.keypedia.com/companies/philips-respironics-inc/03ceee46-7a72-4590-8bc4-8033e1503cf3)
- [Reading Hospital](https://www.keypedia.com/companies/reading-hospital/06325159-9820-479a-ba2e-0f47aaa24d60)
- [Prolacta Bioscience Inc](https://www.keypedia.com/companies/prolacta-bioscience-inc/fafc52a9-8c2a-4c2a-9889-e42779d7c654)
- [Colorado Center for Reproductive Medicine, LC](https://www.keypedia.com/companies/colorado-center-for-reproductive-medicine-lc/ec4fa5b4-cf85-4af1-8e07-b83e0bc8828f)
- [Purdue Pharma L.P.](https://www.keypedia.com/companies/purdue-pharma-lp/12a191f7-7216-4b7c-aa90-a6e20688a346)
- [Biomedix Wai](https://www.keypedia.com/companies/biomedix-wai/35aa0e7f-c8eb-40a8-9b5b-5b57fa435abf)
- [Biomerieux Inc](https://www.keypedia.com/companies/biomerieux-inc/4ca56fd6-0bcf-4144-8cb6-60511d8260b4)
- [Arifulla Khan MD](https://www.keypedia.com/companies/arifulla-khan-md/311edd91-40e3-4296-9283-8ea2b60de005)
- [US Vascular, Inc.](https://www.keypedia.com/companies/us-vascular-inc/32500e78-94f1-4fba-8df5-32eccb7cc967)
- [Nutra Solutions USA, Inc.](https://www.keypedia.com/companies/nutra-solutions-usa-inc/c3b931f1-cf3d-4550-b715-a5e8554a01da)

## Related Officers

- [investigator](https://www.keypedia.com/people/sarah-a-hassas/4f142d54-fc28-4bd5-82ad-7e6fa443688c)